Page 107 - Global Growth Pharmaceuticals & Biotech Stocks

UPDATED Jan 10, 2025

Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

3,213 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

A011040

Kyung Dong Pharmaceutical
₩6,080.00-2.4%-8.3%₩163.8bn/aPB0.8xn/a6.6%

6955

Bonraybio
NT$149.00-3.2%108.2%NT$2.9bn/an/an/a0.1%

A343090

HLB SCIENCE
₩2,220.005.5%7.5%₩36.4bn/an/an/an/a

A018620

WooGene B&G
₩938.003.5%-23.6%₩27.1bn/aPE21.8xn/an/a

6998

Genor Biopharma Holdings
HK$1.892.2%76.6%HK$976.2mn/aPS63.5xn/an/a

ANR

Anatara Lifesciences
AU$0.05612.0%143.5%AU$11.6mn/aPB8.5xn/an/a

A007570

Ilyang PharmaceuticalLtd
₩12,290.000.6%-16.3%₩221.4bn/aPB1xn/a1.2%

603676

Tibet Weixinkang Medicine
CN¥9.41-2.0%-5.8%CN¥4.1bn/aPE16.6xn/a1.7%

1367

Zhejiang Haisen Pharmaceutical
CN¥25.55-4.8%-13.9%CN¥2.6bn/aPE21.9xn/a1.3%

524774

NGL Fine-Chem
₹1,724.70-4.2%-14.2%₹10.7bn/aPE25.8xn/a0.1%

VILINBIO

Vilin Bio Med
₹22.00-8.3%-12.7%₹306.9mn/aPS2.3xn/an/a

SAKAR

Sakar Healthcare
₹294.55-2.8%-28.3%₹6.4bn/aPE51.7xn/an/a

IPAH

Interpharm Holdings
US$0.00410%n/aUS$273.6kn/an/an/an/a

EMBT

Ember Therapeutics
US$0.0000010%n/aUS$43.0n/an/an/an/a

601089

Beijing Foyou PharmaLTD
CN¥14.78-2.8%-13.4%CN¥6.9bn/aPE13.6xn/a3.4%

1652

Fusen Pharmaceutical
HK$0.69-13.8%-48.5%HK$510.1mn/aPS1.1xn/a0%

301281

Shandong Keyuan Pharmaceutical
CN¥27.88-3.0%-11.8%CN¥3.0bn/aPE60.2xn/a1.1%

AVE

Avecho Biotechnology
AU$0.0030%-25.0%AU$9.5mn/aPS28xn/an/a

RGDX.Q

Response Genetics
US$0.0000010%n/aUS$38.0n/an/an/an/a

PFND

Pathfinder Cell Therapy
US$0.0000010%n/aUS$667.0n/an/an/an/a

950

Lee's Pharmaceutical Holdings
HK$1.28-9.9%-11.7%HK$753.7mn/aPE12xn/a2.3%

4896

K PharmaInc
JP¥675.008.7%11.0%JP¥7.8bn/an/an/an/a

OSL

OncoSil Medical
AU$0.005-28.6%-44.4%AU$22.5mn/aPS14.4xn/an/a

SYVC

Synovics Pharmaceuticals
US$0.0000010%n/aUS$36.0n/an/an/an/a
Page 107 of 134